$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

네트워크 약리학 기반 대황목단피탕(大黃牧丹皮湯)의 건선 조절 효능 및 작용 기전 예측
Prediction the efficacy and mechanism of action of Daehwangmokdanpitang to treat psoriasis based on network pharmacology 원문보기

大韓本草學會誌 = The Korea journal of herbology, v.38 no.6, 2023년, pp.73 - 91  

권빛나 (원광대학교 한의과대학 약리학교실) ,  김동욱 (원광대학교 한의과대학 약리학교실) ,  양갑식 (우석대학교 한의과대학 임상약리연구실) ,  조일주 (원광대학교 한의과대학 뇌졸중한의중점연구센터)

Abstract AI-Helper 아이콘AI-Helper

Objectives : This study used a network pharmacology approach to elucidate the efficacy and molecular mechanisms of Daehwangmokdanpitang (DHMDPT) on Psoriasis. Methods : Using OASIS databases and PubChem database, compounds of DHMDPT and their target genes were collected. The putative target genes of...

주제어

표/그림 (8)

참고문헌 (56)

  1. Lee A, Chun J. Prediction of efficacy of the compounds?and atherosclerosis target gene in Yijin-tang based on network pharmacology. Korean Herbal Medicine?Informatics. 2017;5(3):31-42. DOI:10.22674/KHMI5-3-4.? 

  2. Lee AY, Lee J, Chun JM. Prediction of potential?targets efficacy derived from ginger active ingredients?using network pharmacology. Korean Herbal Medicine?Informatics. 2020;8(2):255-66. DOI:10.22674/KHMI8-2-11.? 

  3. Zhang R, Zhu X, Bai H, Ning K. Network pharmacology?databases for traditional Chinese medicine: review?and assessment. Frontiers in pharmacology. 2019;10:123. DOI:10.3389/fphar.2019.00123.? 

  4. Hopkins AL. Network pharmacology. Nature?Biotechnology. 2007;25(10):1110-1. DOI:10.1038/nbt1007-1110.? 

  5. Lee WY, Lee CY, Kim YS, Kim CE. The Methodological?Trends of Traditional Herbal Medicine Employing?Network Pharmacology. Biomolecules. 2019;9(8):362.?DOI:10.3390/biom9080362.? 

  6. Kweon BN, Ryu SM, Kim DU, Oh JY, Jang MK, Park SJ, Bae GS. Network pharmacology-based prediction?of efficacy and mechanism of Chongmyunggongjindan acting on Alzheimer's disease. Journal of Korean?Medicine. 2023;44(2):106-18.? 

  7. Han CY, Kim JD, Seo GY, Kim KS, Kim YB.?Investigation of Effective Korean Herbal Medicine?for Psoriasis. The Korean Medicine Ophthalmology?& Otolaryngology & Dermatology. 2021;34(3):70-9.? 

  8. Kim JY, Choi MR, Choi CW, Park KD, Lee Y, Kim?CD, Seo YJ, Lee JH. Immunohistochemical Study of?Psoriasis-related Gene Expression in Imiquimod-induced Psoriasis-like Mouse Model. Korean?Journal of Dermatology. 2018:609-13.? 

  9. Guttman-Yassky E, Nograles KE, Krueger JG.?Contrasting pathogenesis of atopic dermatitis and?psoriasis-part I: clinical and pathologic concepts.?The Journal of allergy and clinical immunology.?2011;127(5):1110-8. DOI:10.1016/j.jaci.2011.01.053.? 

  10. Kamiya K, Kishimoto M, Sugai J, Komine M,?Ohtsuki M. Risk factors for the development of?psoriasis. International journal of molecular sciences.?2019;20(18):4347. DOI:10.3390/ijms20184347.? 

  11. Christophers E. Psoriasis--epidemiology and?clinical spectrum. Clinical and experimental?dermatology. 2001;26(4):314-20. DOI:10.1046/j.1365-2230.2001.00832.x.? 

  12. Lee JY, Kang SC, Park JS, Jo SJ. Prevalence of?psoriasis in Korea: a population-based epidemiological?study using the Korean National Health Insurance?Database. Annals of dermatology. 2017;29(6):761-7.?DOI:10.5021/ad.2017.29.6.761.? 

  13. Kang DW, Han CY, Kim JD, Kim KS, Kim YB. A?Proposal and Considerations for Treatment?Approaches of Psoriasis. The Korean Medicine?Ophthalmology & Otolaryngology & Dermatology.?2020;33(3):99-114. DOI:10.6114/jkood.2020.33.3.099.? 

  14. Jung KJ, Kim TG, Lee JW, Lee M, Oh J, Lee SE,?Chang HJ, Jee SH, Lee MG. Increased risk of?atherosclerotic cardiovascular disease among patients?with psoriasis in Korea: A 15-year nationwide?population-based cohort study. The Journal of?dermatology. 2019;46(10):859-66. DOI:10.1111/1346-8138.15052.? 

  15. Greb JE, Goldminz AM, Elder JT, Lebwohl MG,?Gladman DD, Wu JJ, Mehta NN, Finlay AY, Gottlieb?AB. Psoriasis. Nature reviews. Disease primers.?2016;24(2):16082. DOI:10.1038/nrdp.2016.82.? 

  16. Kim NK, Hwang C, Lim GS. The oriental and?occidental bibliographic study of psoriasis. The?Korean Medicine Ophthalmology & Otolaryngology?& Dermatology. 1999;12(1):154-78.? 

  17. Cho EC, Kim KS. A Review on Patterns and?Classification Criteria of Psoriasis by analyzing?Chinese Theses. The Journal of Korean Medicine?Ophthalmology & Otolaryngology & Dermatology.?2020;33(2):112-29. DOI:10.6114/jkood.2020.33.2.112.? 

  18. Kim BH, Kim KI, Kang SH, Park JG, Kang DW,?Nam HJ, Kim YB, Lee JH, Kim KS. Explanation?and Elaboration of the Clinical Trial Guidelines for?Psoriasis Using Herbal Medicine. The Journal of?Korean Medicine Ophthalmology and Otolaryngology?and Dermatology. 2018;31(2):40-59. DOI:10.6114/jkood.2018.31.2.040.? 

  19. Kim SM, Sun JJ, Choi CM, Jung JH, Hwang JW,?Min IK, Kim CH, Jung WS, Moon SK, Cho KH,?Kim YS, Bae HS. The Relationship among Bloodstasis, CAVI and Cardiovascular Risk in Stroke?Patients. The Journal of Internal Korean Medicine.?2007;28(3):421-33.? 

  20. Reich K. The concept of psoriasis as a systemic?inflammation: implications for disease management.?Journal of the European Academy of Dermatology?and Venereology. 2012;26:3-11. DOI:10.1111/j.1468-3083.2011.04410.x.? 

  21. Medicine C-ebapoFatCoO. Formular Study. Seoul:?Younglim; 1999. 609-10 p.? 

  22. Park SJ, Jeong JG, Seo SW, Hwang SW, Kim YW,?Song DS, Chae YS, Shin MK, Song HJ. Effects of?Gami-Daehwangmokdanpi-Tang against CCK-induced acute pancreatitis. The Korea Journal of?Herbology. 2005;20(3):59-65.? 

  23. Keisetsu O. Characteristics of Oriental Medicine.?Seoul: ChonpaScience; 2017. 192 p.? 

  24. Nguyen LTH, Ahn SH, Shin HM, Yang IJ. Anti-Psoriatic Effect of Rheum palmatum L. and Its?Underlying Molecular Mechanisms. International?Journal of Molecular Sciences. 2022;23(24). DOI:10.3390/ijms232416000.? 

  25. Lee MH, Hong SH, Park C, Han MH, Kim SO,?Hong SH, Kim GY, Choi YH. Anti-inflammatory?effects of Daehwangmokdantang, a traditional?herbal formulation, in lipopolysaccharide-stimulated?RAW 264.7 macrophages. Experimental and?Therapeutic Medicine. 2017;14(6):5809-16. DOI:10.3892/etm.2017.5296.? 

  26. Jeon DJ, Cha YY, Lee E. Inflammatory Effect of?Rheum undulatum L. Journal of Korean Medicine?Rehabilitation. 2011;21(1):35-46.? 

  27. Kim HY, Seol IC, Yoo HR, Kim YS. The Effect of?Trichosanthes Kirilowii Maximowicz Extract and?Trichosanthes Kirilowii Maximowicz Cheonghyeol?Plus on Anti-Inflammatory Factor Expression in Human Umbilical Vein Endothelial Cells (HUVECs).?The Journal of Internal Korean Medicine. 2022;43(4):514-28. DOI:10.22246/jikm.2022.43.4.514.? 

  28. Park JH, Kim KJ. The Effect of Moutan Cortex on Pro-inflammatory Cytokines through NF-κB &?MAPKs pathway in HMC-l. The Journal of Korean?Medicine Ophthalmology and Otolaryngology and?Dermatology. 2009;22(2):1-18.? 

  29. Joe WA, Jang MJ, Cheon SJ, Sung JY, Choi EY,?Kang BY, Jung SH, Jung YS, Kim YS, An BJ, Lee?CA, Lee JT. Cosmeceutical activities and Anti-inflammatory effects of Shell from Persicae semen.?The Korea Journal of Herbology. 2006;21(2):87-93.? 

  30. Oh KK, Adnan MD, Cho DH. A network pharmacology?analysis on drug-like compounds from Ganoderma?lucidum for alleviation of atherosclerosis. Journal of?Food Biochemistry. 2021;45(9):e13906. DOI:10.1111/jfbc.13906.? 

  31. Zhang L, Shi X, Huang Z, Mao J, Mei W, Ding L,?Zhang L, Xing R, Wang P. Network pharmacology?approach to uncover the mechanism governing the?effect of radix achyranthis bidentatae on osteoarthritis.?BMC complementary medicine and therapies. 2020;20(1):121. DOI:10.1186/s12906-020-02909-4.? 

  32. Wen Y, Zhan Y, Tang S, Kang J, Wu R, Tang X.?Mechanistic prediction of Chinese herb compound?(Zhi Zhu Ma Ren Pill) in the treatment of constipation?using network pharmacology and molecular docking.?Natural Product Communications. 2022;17(9). DOI:10.1177/1934578X221124780.? 

  33. Lipinski CA. Lead- and drug-like compounds: the?rule-of-five revolution. Drug Discovery Today?Technologies. 2004;1(4):337-41. DOI:10.1016/j.ddtec.2004.11.007.? 

  34. Matsson P, Kihlberg J. How big is too big for cell?permeability? : ACS Publications; 2017 : 1662-4.?DOI:10.1021/acs.jmedchem.7b00237.? 

  35. Muhr P, Zeitvogel J, Heitland I, Werfel T,?Wittmann M. Expression of interleukin (IL)-1?family members upon stimulation with IL-17 differs?in keratinocytes derived from patients with psoriasis?and healthy donors. The British Journal of?Dermatology. 2011;165(1):189-93. DOI:10.1111/j.1365-2133.2011.10302.x.? 

  36. Gran F, Kerstan A, Serfling E, Goebeler M,?Muhammad K. Focus: Skin: Current Developments?in the Immunology of Psoriasis. The Yale journal of?biology and medicine. 2020;93(1):97.? 

  37. Tian S, Krueger JG, Li K, Jabbari A, Brodmerkel?C, Lowes MA, Suarez-Farinas M. Meta-analysis?derived (MAD) transcriptome of psoriasis defines the?"core" pathogenesis of disease. Plos One. 2012;7(9):e44274. DOI:10.1371/journal.pone.0044274.? 

  38. Suarez-Farinas M, Li K, Fuentes-Duculan J, Hayden?K, Brodmerkel C, Krueger JG. Expanding the?psoriasis disease profile: interrogation of the skin?and serum of patients with moderate-to-severe?psoriasis. Journal of Investigative Dermatology.?2012;132(11):2552-64. DOI:10.1038/jid.2012.184.? 

  39. Song HJ, Park CJ, Kim TY, Choe YB, Lee SJ, Kim?NI, Cho JW, Jeon JH, Jang MS, Youn JI, Kim MH,?Park JS, Kim KH, Kim BS, Youn SW, Lee JH, Lee?MG, Ahn SK, Won YH, Yun SK, Shin BS, Seo SJ,?Lee JY, Kim KJ, Ro YS, Kim YD, Yu DY, Choi JH.?The Clinical Profile of Patients with Psoriasis in?Korea: A Nationwide Cross-Sectional Study (EPIPSODE). Annals of dermatology. 2017;29(4):462-70. DOI:10.5021/ad.2017.29.4.462.? 

  40. Kang DW, Han CY, Kim JD, Kim KS, Kim YB. A?Proposal and Considerations for Treatment?Approaches of Psoriasis. The Journal of Korean?Medicine Ophthalmology & Otolaryngology &?Dermatology. 2020;33(3):99-114. DOI:10.6114/jkood.2020.33.3.099.? 

  41. Jo IJ. Inhibitory activity of Terminalia chebula?extract against TNF-α/IFN-γ-induced chemokine?increase on human keratinocyte, HaCaT cells. The?Korea Journal of Herbology. 2022;37(3):41-7.? 

  42. Guo S, Zhou JY, Tan C, Shi L, Shi Y, Shi J. Network?Pharmacology-Based Analysis on the Mechanism?of Action of Ephedrae Herba-Cinnamomi Ramulus?Couplet Medicines in the Treatment for Psoriasis.?Medical Science Monitor. 2021;27:e927421. DOI:10.12659/MSM.927421.? 

  43. Yue C, Feng J, Gao A. A network pharmacology and?molecular docking investigation on the mechanisms?of Shanyaotianhua decoction (STT) as a therapy?for psoriasis. Medicine. 2023;102(34):e34859. DOI:10.1097/MD.0000000000034859.? 

  44. Ioannou M, Sourli F, Mylonis I, Barbanis S,?Papamichali R, Kouvaras E, Zafiriou E, Siomou P,?Klimi E, Simos G, Roussaki-Schulze AV, Koukoulis?G. Increased HIF-1 alpha immunostaining in psoriasis?compared to psoriasiform dermatitides. Journal of?cutaneous pathology. 2009;36(12):1255-61. DOI:10.1111/j.1600-0560.2009.01264.x.? 

  45. Blauvelt A. IL-6 Differs from TNF-alpha: Unpredicted?Clinical Effects Caused by IL-6 Blockade in Psoriasis.?The Journal of Investigative Dermatology. 2017;137(3):541-2. DOI:10.1016/j.jid.2016.11.022.? 

  46. Vasilopoulos Y, Sourli F, Zafiriou E, Klimi E, Ioannou?M, Mamuris Z Simos G, Koukoulis G, RoussakiSchulze A. High serum levels of HIF-1alpha in?psoriatic patients correlate with an over-expression of IL-6. Cytokine. 2013;62(1):38-9. DOI:10.1016/j.cyto.2013.02.029.? 

  47. Tang YY, Wang DC, Wang YQ, Huang AF, Xu WD.?Emerging role of hypoxia-inducible factor-1α in?inflammatory autoimmune diseases: A comprehensive?review. Frontiers in Immunology. 2023;13:1073971.?DOI:10.3389/fimmu.2022.1073971.? 

  48. Mosca M, Hong J, Hadeler E, Hakimi M, Liao W,?Bhutani T. The role of IL-17 cytokines in psoriasis.?ImmunoTargets and therapy. 2021:409-18. DOI:10.2147/ITT.S240891.? 

  49. Furue M, Furue K, Tsuji G, Nakahara T. Interleukin-17A and Keratinocytes in PsoriasisInternational?Journal of Molecular Sciences. 2020;21(4). DOI:10.3390/ijms21041275.? 

  50. Cai Y, Xue F, Quan C, Qu M, Liu N, Zhang Y,?Fleming C, Hu X, Zhang HG, Weichselbaum R, Fu?YX, Tieri D, Rouchka EC, Zheng J, Yan J. A?Critical Role of the IL-1beta-IL-1R Signaling?Pathway in Skin Inflammation and Psoriasis?Pathogenesis. The Journal of Investigative?dermatology. 2019;139(1):146-56. DOI:10.1016/j.jid.2018.07.025.? 

  51. Lai CY, Su YW, Lin KI, Hsu LC, Chuang TH.?Natural Modulators of Endosomal Toll-Like?Receptor-Mediated Psoriatic Skin Inflammation.?Journal of Immunology Research. 2017;2017:7807313.?DOI:10.1155/2017/7807313.? 

  52. Mylonas A, Conrad C. Psoriasis: Classical vs.?Paradoxical. The Yin-Yang of TNF and Type I?Interferon. Frontiers in Immunology. 2018;9:2746.?DOI:10.3389/fimmu.2018.02746.? 

  53. Wikan N, Hankittichai P, Thaklaewphan P,?Potikanond S, Nimlamool W. Oxyresveratrol Inhibits?TNF-alpha-Stimulated Cell Proliferation in Human?Immortalized Keratinocytes (HaCaT) by Suppressing?AKT Activation. Pharmaceutics. 2021;14(1):63.?DOI:10.3390/pharmaceutics14010063.? 

  54. Song YI, Oh MS. Anti-inflammatory Effect of?Gyulpidaehwangbakcho-tang (Jupidahuangpoxiaotang) in the Collagen-induced Arthritis Mouse Model.?Journal of Korean Medicine. 2011;32(6):18-29.? 

  55. Sohn YJ, Kang HC, Kim KS, Park SM, Sohn NW,?Jung HS, Kim SH. Protective effects of natrii sulfas on cerebral focal ischemia induced by MCAO in rats.?The American Journal of Chinese Medicine. 2009;?37(02):273-93. DOI:10.1142/S0192415X09006849.? 

  56. Kim KS, Kim BH, Lee DE, Kim SJ, Kang H, Sohn?NW, Yang KY. Effects of Purgative Action with?Natrii Sulfas on Bax and HSP72 Expressions of the?MCAO Rat Brain. Journal of Physiology & Pathology?in Korean Medicine. 2009;23(4):818-24.? 

관련 콘텐츠

오픈액세스(OA) 유형

FREE

Free Access. 출판사/학술단체 등이 허락한 무료 공개 사이트를 통해 자유로운 이용이 가능한 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로